Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From Shareholder letter..

From Shareholder letter..

posted on Sep 27, 2006 07:15PM
PTSC has enlisted the services of JM Dutton & Co http://www.jmdutton.com/index.html A semi recent (Feb '05) pic of JM Dutton was Neoprobe Corp NEOP.ob They called for a price target of $1.70, they did hit .70 http://finance.yahoo.com/q/bc?s=NEOP.OB&t=2y&l=on&z=m&q=l&c= and the expected result there after... Honestly this is the only one I checked, perhaps the others they rep have done better (they appear to cover some 70 or so cos). Also mentioned in the SH letter, the services of the Shareholder Development Group.. http://www.shareholderdg.com/profile1_PTSC.asp Their 'Comprehensive' report does not mention the MMP either. My point here is it seems as if we have paid an endless supply of investment firms for supposedly covering PTSC.. Incuding Hoffman currently. Perhaps I am blind but I fail to see any significant or obvious benefit for PTSC from any of the previous firms.. I understand the importance of getting PTSC's story out there.. and if they have to go thru all the investment firms out there, so be it. I just wish the money PTSC was chronically spending on these firms would produce the desired result/s

Sep 28, 2006 03:49AM

Sep 28, 2006 06:07AM
Share
New Message
Please login to post a reply